Geoffrey M. Parker - 16 May 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/Earl Douglas, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
16 May 2024
Net transactions value
+$1,000,001
Form type
4
Filing time
20 May 2024, 18:02:28 UTC
Previous filing
16 May 2024
Next filing
23 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $1,000,001 +344,828 +42% $2.90 1,164,418 16 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.